Clinical Trial Update: A Trial of Centanafadine Efficacy and Safety in Adolescents With Attention- Deficit/Hyperactivity Disorder [Phase 3]

View source ↗

Summary

The document reports that a Phase 3 trial evaluating centanafadine for adolescents with attention-deficit/hyperactivity disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Centanafadine (centanafadine)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Attention-Deficit/Hyperactivity Disorder | Phase 3 | Status: COMPLETED